disease: 10-year results of a randomized trial extended field radiation therapy in early and intermediate Hodgkin's (ABVD) or Epirubicin, Bleomycin, Velban, and Methotrexate (EBVM) plus Three cycles of Adriamycin, Bleomycin, Velban, and Dacarbazine